These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7805705)

  • 1. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
    Lister RE; Acerbi D; Cadel S
    Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
    Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
    Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrocyclic molecules and their pharmacological applications.
    Lasagna L
    Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
    [No Abstract]   [Full Text] [Related]  

  • 4. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
    Lee CR; Balfour JA
    Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
    Cadel S; Bongrani S
    Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
    Wang D; Miller R; Zheng J; Hu C
    J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
    Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
    Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
    Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
    Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
    Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
    Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the antalgic activity and tolerability of piroxicam in chronic pain in cervicoarthrosis and lumboarthrosis].
    Minisola G; Dardano B
    Clin Ter; 1989 Oct; 131(2):73-82. PubMed ID: 2533023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.
    Acerbi D; Bonati C; Boscarino G; Bufalino L; Cesari F; D'Ambrosio E; Mansanti P; Scali G
    Int J Clin Pharmacol Res; 1988; 8(3):175-80. PubMed ID: 3403105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
    Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piroxicam-β-cyclodextrin: a GI safer piroxicam.
    Scarpignato C
    Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
    Serni U
    Eur J Rheumatol Inflamm; 1993; 12(4):47-54. PubMed ID: 7805704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prizes!
    Huskisson EC
    Eur J Rheumatol Inflamm; 1993; 12(4):1-2. PubMed ID: 7805699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative endoscopic study of gastroduodenal tolerance of piroxicam-beta-cyclodextrin vs piroxicam].
    Müller P; Simon B
    Z Rheumatol; 1997; 56(2):76-9. PubMed ID: 9235813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemicrania continua: a case responsive to piroxicam-beta-cyclodextrin.
    Trucco M; Antonaci F; Sandrini G
    Headache; 1992 Jan; 32(1):39-40. PubMed ID: 1555930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.